CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 5,000 shares of the firm’s stock in a transaction dated Monday, June 11th. The stock was sold at an average price of $50.51, for a total value of $252,550.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
V Gordon Clemons also recently made the following trade(s):
- On Wednesday, June 13th, V Gordon Clemons sold 6,500 shares of CorVel stock. The stock was sold at an average price of $50.52, for a total value of $328,380.00.
- On Wednesday, June 6th, V Gordon Clemons sold 5,000 shares of CorVel stock. The stock was sold at an average price of $51.59, for a total value of $257,950.00.
NASDAQ CRVL traded up $0.55 during trading hours on Thursday, hitting $51.40. The company had a trading volume of 1,047 shares, compared to its average volume of 33,078. CorVel Co. has a 52 week low of $44.81 and a 52 week high of $61.20. The company has a market cap of $967.16 million, a P/E ratio of 27.30 and a beta of 0.68.
CorVel (NASDAQ:CRVL) last issued its earnings results on Thursday, May 31st. The business services provider reported $0.47 EPS for the quarter. CorVel had a return on equity of 23.11% and a net margin of 6.39%. The business had revenue of $143.57 million during the quarter.
Separately, BidaskClub upgraded CorVel from a “hold” rating to a “buy” rating in a research note on Tuesday, March 13th.
Hedge funds and other institutional investors have recently modified their holdings of the business. LS Investment Advisors LLC boosted its position in shares of CorVel by 424.0% during the 4th quarter. LS Investment Advisors LLC now owns 2,033 shares of the business services provider’s stock valued at $108,000 after acquiring an additional 1,645 shares during the last quarter. SG Americas Securities LLC boosted its position in shares of CorVel by 90.9% during the 4th quarter. SG Americas Securities LLC now owns 3,583 shares of the business services provider’s stock valued at $190,000 after acquiring an additional 1,706 shares during the last quarter. Crossmark Global Holdings Inc. bought a new stake in shares of CorVel during the 4th quarter valued at about $270,000. MetLife Investment Advisors LLC bought a new stake in shares of CorVel during the 4th quarter valued at about $282,000. Finally, Allianz Asset Management GmbH bought a new stake in shares of CorVel during the 4th quarter valued at about $294,000. Institutional investors and hedge funds own 43.97% of the company’s stock.
CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.